V006-4056 Screening compound: 2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-4-carboxamide

V006-4056 Screening compound: 2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-4-carboxamide
V006-4056 Screening compound: 2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-4056
2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-4056

Molecular Formula

C37H46N4O2S (C37 H46 N4 O2 S)

Compound Name

2-({[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-4-carboxamide

IUPAC name

2-({[(4-tert-butylphenyl)methyl](33-diphenylpropyl)amino}methyl)-N-[2-(morpholin-4-yl)ethyl]-13-thiazole-4-carboxamide

SMILES

CC(C)(C)c1ccc(CN(CCC(c2ccccc2)c2ccccc2)Cc2nc(C(NCCN3CCOCC3)=O)cs2)cc1

InChI

InChI=1S/C37H46N4O2S/c1-37(2,3)32-16-14-29(15-17-32)26-41(20-18-33(30-10-6-4-7-11-30)31-12-8-5-9-13-31)27-35-39-34(28-44-35)36(42)38-19-21-40-22-24-43-25-23-40/h4-17,28,33H,18-27H2,1-3H3,(H,38,42)

InChI Key

NZXQGKLMYIOLPT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19766915

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

610.86

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.988

Distribution Coefficient, logD

6.958

Water Solubility, LogSw

-5.73

Polar Surface Area

50.032

Acid Dissociation Constant (pKa)

13.28

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.54

V006-4056 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V006-4056 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-4056?
Check Price and Availability of V006-4056, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-4056 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-4056
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-4056
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-4056 available by request